Login or Sign Up
12:28 Jun 25
Concord Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Concord Drugs Ltd. Financials
Concord Drugs Ltd.
Industry Pharmaceuticals
12:28 Jun 25
Quality
62/100
High Financial Strength
Valuation
42/100
Mid Valuation
Technical
45/100
Technically Neutral
Strength
10
Weakness
3
Opportunity
0
Threats
0
2.17 %
ROE %
1.40 %
ROA %
0.00
EPS
36.82
BVPS
1.33 %
Net Profit Margin
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | ||
|---|---|---|---|---|---|
| Net Sales | 52.08 | 44.92 | 45.24 | 78.74 | |
| Operating Expenses + | 47.5 | 40.87 | 41.11 | 74.22 | |
| Raw Material | 41.16 | 31.1 | 35.81 | 68.03 | |
| Increase Decrease in Cost | -0.16 | 2.16 | -0.58 | -0.38 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | |
| Employee Cost | 4.92 | 6.08 | 4.63 | 4.97 | |
| Miscellaneous Expenses | 1.58 | 1.53 | 1.25 | 1.6 | |
| Operating Profit | 4.58 | 4.05 | 4.13 | 4.52 | |
| Other Income | 0.01 | 0.01 | 0.01 | 0.03 | |
| Depreciation | 1.63 | 1.56 | 1.43 | 1.37 | |
| Interest | 1.71 | 1.87 | 2.03 | 1.71 | |
| Profit before tax and exceptio.. | 1.25 | 0.63 | 0.69 | 1.47 | |
| Exceptional Items | 0 | 0 | 0 | 0 | |
| PBT | 1.25 | 0.63 | 0.69 | 1.47 | |
| Provision for Taxation | 0.26 | 0.16 | 0.36 | 0.42 | |
| Net Profit | 0.99 | 0.47 | 0.34 | 1.06 | |
| NET Profit after MI | 0.99 | 0.47 | 0.34 | 1.06 | |
| EPS | 1.06 | 0.47 | 0.34 | 0.95 | |
| Operating Profit Margin (%) | 8.79 | 9.02 | 9.13 | 5.74 | |
| Net Profit Margin (%) | 1.9 | 1.05 | 0.75 | 1.35 |
Concord Drugs Ltd. Shareholding
All Data in Percentage (%)
| Promoter | - | - | - | - | - |
| FII | - | - | - | - | - |
| Public | - | - | - | - | - |
| MF | - | - | - | - | - |
| Others |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully